Welcome to the biweekly electronic newsletter from the Bio-X Program at Stanford University for members of the Bio-X Corporate Forum. Please contact us if you would like to be added or removed from this distribution list, or if you have any questions about Bio-X or Stanford.


Seed Grant Program

SEED GRANTS FOR SUCCESS - Stanford Bio-X Interdisciplinary Initiatives Program (IIP)

The Bio-X Interdisciplinary Initiatives Program represents a key Stanford Initiative to address challenges in human health. The IIP awards approximately $3 million every other year in the form of two-year grants averaging about $150,000 each. From its inception in 2000 through the fifth round in 2010, the program has provided critical early-stage funding to 114 different interdisciplinary projects, involving collaborations from over 300 faculty members, and creating over 450 teams from five different Stanford schools. From just the first 4 rounds, the IIP awards have resulted in a tenfold-plus return on investment, as well as hundreds of publications, dozens of patents filed, and most importantly, the acceleration of scientific discovery and innovation.

THIS YEAR, IN OUR 6TH ROUND OF SEED GRANTS, WE'VE RECEIVED 118 LETTERS OF INTENT (LOIs), AND WE'RE CURRENTLY IN THE PROCESS OF REVIEWING THE SELECTED LOIs, WHICH WILL HAVE FULL PROPOSALS AS PART OF THEIR SEED GRANT APPLICATIONS. Competition is intense, and the criteria for the proposals include innovation, high-reward, and interdisciplinary collaboration. To view the 114 different projects that have been funded from the first 5 rounds, please click here.

** Each year, Bio-X holds 2 annual IIP symposia which showcases the awarded seed grant projects. The next IIP symposium will take place on MONDAY, AUGUST 27, 2012 in the Clark Center Auditorium. The latest symposium was held on February 13, 2012, and over 150 attendants were present for the 8 podium presentations and 103 poster presentations. The recorded talks are now online.

We are cultivating and are highly successful in building meaningful collaborations with numerous corporate colleagues. New collaborations through our seed grant projects are highly encouraged. To learn about how to get involved, please contact Dr. Hanwei Li or Dr. Heideh Fattaey.

 


Fellowships

BIO-X FELLOWSHIPS

Every year, graduate students and postdoctoral scholars of Bio-X affiliated faculty are highly encouraged to apply for the Bio-X Fellowships, which are awarded to research projects that are interdisciplinary and utilize the technologies of different fields to solve different biological questions. Students are encouraged to work collaboratively with professors of different departments, thus creating cross-disciplinary relationships among the different Stanford schools. Our fellows have conducted exciting research, resulting in publications in high-impact journals and have been offered excellent positions in industry and academia.

** On Thursday June 21, 2012, our 18 newest Bio-X Fellowship awardees were just announced at the BIO-X FELLOWS SYMPOSIUM. The symposium also consisted of four 15-minute presentations and thirty-five 1-minute research introductions that truly demonstrated the synergy of different yet distinctive disciplines, merged together to address various life bioscience questions. To date, we now have a total of 126 Bio-X Fellows. To view the numerous projects that have been awarded over the years, please click here.

Many fruitful collaborations and relationships have been established with industry through these fellowships. Please contact Dr. Hanwei Li or Dr. Heideh Fattaey if you'd like to learn more about how to get involved with the Bio-X Fellowships.

 


News

Protein–inorganic hybrid nanoflowers
Publication in Nature Nanotechnology by Bio-X Affiliated Faculty Richard Zare
UPDATE: Figure as the cover of journal's July 2012 edition
Abstract: Flower-shaped inorganic nanocrystals have been used for applications in catalysis and analytical science, but so far there have been no reports of 'nanoflowers' made of organic components. Here, we report a method for creating hybrid organic-inorganic nanoflowers using copper (II) ions as the inorganic component and various proteins as the organic component. The protein molecules form complexes with the copper ions, and these complexes become nucleation sites for primary crystals of copper phosphate. Interaction between the protein and copper ions then leads to the growth of micrometre-sized particles that have nanoscale features and that are shaped like flower petals. When an enzyme is used as the protein component of the hybrid nanoflower, it exhibits enhanced enzymatic activity and stability compared with the free enzyme. This is attributed to the high surface area and confinement of the enzymes in the nanoflowers.


New method enables sequencing of fetal genomes using only maternal blood sample
Bio-X Affiliated Faculty Stephen Quake
Researchers at Stanford University have for the first time sequenced the genome of an unborn baby using only a blood sample from the mother. The findings from the new approach, published July 4 in Nature, are related to research that was reported a month ago from the University of Washington. That research used a technique previously developed at Stanford to sequence a fetal genome using a blood sample from the mother, plus DNA samples from both the mother and father. The whole genome sequencing in the new Stanford study, however, did not require DNA from the father — a significant advantage when a child’s true paternity may not be known (a situation estimated to affect as many as one in 10 births in this country) or the father may be unavailable or unwilling to provide a sample. The technique brings fetal genetic testing one step closer to routine clinical use. “We’re interested in identifying conditions that can be treated before birth, or immediately after,” said Stephen Quake, PhD, the Lee Otterson Professor in the School of Engineering and professor of bioengineering and of applied physics. “Without such diagnoses, newborns with treatable metabolic or immune system disorders suffer until their symptoms become noticeable and the causes determined.” Quake is the senior author of the research. Former graduate student H. Christina Fan, PhD, now a senior scientist at ImmuMetrix, and current graduate student Wei Gu are co-first authors of the article.


Stanford scientists develop ultrafast nickel-iron battery
Bio-X Affiliated Faculty Hongjie Dai
Stanford University scientists have breathed new life into the nickel-iron battery, a rechargeable technology developed by Thomas Edison more than a century ago. Designed in the early 1900s to power electric vehicles, the Edison battery largely went out of favor in the mid-1970s. Today only a handful of companies manufacture nickel-iron batteries, primarily to store surplus electricity from solar panels and wind turbines. "The Edison battery is very durable, but it has a number of drawbacks," said Hongjie Dai, professor of chemistry. "A typical battery can take hours to charge, and the rate of discharge is also very slow." Now, Dai and his colleagues have dramatically improved the performance of this century-old technology. The Stanford team has created an ultrafast nickel-iron battery that can be fully charged in about 2 minutes and discharged in less than 30 seconds. The results are published in the June 26 issue of the journal Nature Communications. Graduate student Hailiang Wang, lead author of the study, said the team managed to increase the charging and discharging rate by nearly 1,000 times. "We've made it really fast," Wang said. The high-performance, low-cost battery could someday be used to help power electric vehicles, much as Edison originally intended, Dai said. "Hopefully we can give the nickel-iron battery a new life," he added.


Stanford researchers synthesize printable, electrically conductive gel
Bio-X Affiliated Faculty Zhenan Bao and Yi Cui
Stanford researchers have invented an electrically conductive gel that is quick and easy to make, can be patterned onto surfaces with an inkjet printer and demonstrates unprecedented electrical performance.The material, created by Stanford chemical engineering Associate Professor Zhenan Bao, materials science and engineering Associate Professor Yi Cui and members of their labs, is a kind of conducting hydrogel – a jelly that feels and behaves like biological tissues, but conducts electricity like a metal or semiconductor. That combination of characteristics holds enormous promise for biological sensors and futuristic energy storage devices, but has proven difficult to manufacture until now. The research appears this month in the journal PNAS. Bao and Cui made the gel by binding long chains of the organic compound aniline together with phytic acid, found naturally in plant tissues. The acid is able to grab up to six polymer chains at once, making for an extensively cross-linked network. "There are already commercially available conducting polymers," said Bao, "but they all form a uniform film without any nanostructures." In contrast, the new gel's cross-linking makes for a complex, sponge-like structure. The hydrogel is marked with innumerable tiny pores that expand the gel's surface area, increasing the amount of charge it can hold, its ability to sense chemicals, and the rapidity of its electrical response.

 


Events

Pathology
July 10, 2012, 12 pm - 1 pm
Li Ka Shing Center, LK130, Stanford, CA
“Anatomic Pathology in the Molecular Era: SMART Precision Diagnostics”
Speaker: Jennifer L. Hunt, MD, University of Arkansas for Medical Sciences
Molecular Imaging Program at Stanford
July 17, 2012, 11 am - 12 pm
Clark Center Auditorium, Stanford, CA
“Industrialization of Healthcare”
Speaker: Hermann Requardt, PhD, Siemens Healthcare
Cardiovascular Institute
July 17, 2012, 12 pm - 1 pm
Munzer Auditorium, Stanford, CA
"Modeling Human Cardiovascular Development with Pluripotent Stem Cells"
Speaker: Gordon Keller, PhD, Ontario Cancer Institute
Bio-X
August 27, 2012
Clark Center, Stanford, CA
SAVE THE DATE! - Bio-X Interdisciplinary Initiatives Symposium
Speakers to be announced soon!

 


Resources

Stanford University
Bio-X at Stanford University
Bio-X Seed Grants
The Bio-X Interdisciplinary Initiatives Program (IIP) provides seed funding for high-risk, high-reward, collaborative projects across the university, and have been highly successful in fostering transformative research.
Office of Technology and Licensing "Techfinder"
Search the OTL Technology Portal to find technologies available for licensing from Stanford.
Stanford Center for Professional Development
- Take advantage of your FREE membership!
- Take online graduate courses in engineering, leadership and management, bioscience, and more.
- Register for free webinars and seminars, and gets discounts on courses.
Stanford Biodesign Video Tutorials on how FDA approves medical devices
A series of video briefs recently produced by the Stanford Biodesign Program teaches innovators how to get a medical device approved for use in the United States. This free, online library of 60 videos provides detailed information on the Food and Drug Administration regulatory process, short case studies and advice on interacting with the FDA.

To learn more about Bio-X or Stanford University, please contact Dr. Hanwei Li, the Corporate Forum Liaison of Bio-X, at 650-725-1523 or lhanwei1@stanford.edu, or Dr. Heideh Fattaey, the Executive Director of Bio-X Operations and Programs, at 650-799-1608 or hfattaey@stanford.edu.

Release Date: 
July 09, 2012